Targeting HDAC6 to treat heart failure with preserved ejection fraction in miceSara Ranjbarvaziri, Jin Yang, Charles Mackay et al.|Nature Communications|2024Cited by 50
AAV9:PKP2 improves heart function and survival in a Pkp2-deficient mouse model of arrhythmogenic right ventricular cardiomyopathyIris Wu, Zhihong Jane Yang, Aliya Zeng et al.|Communications Medicine|2024Cited by 46
AAV9-mediated MYBPC3 gene therapy with optimized expression cassette enhances cardiac function and survival in MYBPC3 cardiomyopathy modelsAmara Greer-Short, Laura M. Lombardi, Anna Greenwood et al.|Nature Communications|2025Cited by 32
Author Correction: Targeting HDAC6 to treat heart failure with preserved ejection fraction in miceSara Ranjbarvaziri, Jin Yang, Aliya Zeng et al.|Nature Communications|2024Cited by 3
Co-Administration of Inhibitors of HDAC6 and SGLT2 in Murine HFpEF Models Results in Additive Improvements in Cardiac Structural and Functional MeasuresFarshad Farshidfar, Timothy Hoey, Aliya Zeng et al.|Journal of Cardiac Failure|2024Cited by 2